Access cutting-edge advanced cancer treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
This study is researching an investigational drug called REGN7075 by itself and in combination with cemiplimab with or without chemotherapy. The study is focused on patients with certain solid tumors that are in an advanced stage. The aim of the study is to see how safe and tolerable REGN7075 is by itself and in combination with cemiplimab (with or without chemotherapy), and to find out what is the best dose of REGN7075 to be given to patients with advanced solid tumors when combined with cemipl
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this advanced cancer clinical trial in Iowa City, IA
If you're searching for advanced cancer treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.